L M Parker

3.5k total citations · 1 hit paper
24 papers, 2.6k citations indexed

About

L M Parker is a scholar working on Oncology, Reproductive Medicine and Genetics. According to data from OpenAlex, L M Parker has authored 24 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 6 papers in Reproductive Medicine and 5 papers in Genetics. Recurrent topics in L M Parker's work include Cancer Treatment and Pharmacology (9 papers), Ovarian cancer diagnosis and treatment (6 papers) and Breast Cancer Treatment Studies (5 papers). L M Parker is often cited by papers focused on Cancer Treatment and Pharmacology (9 papers), Ovarian cancer diagnosis and treatment (6 papers) and Breast Cancer Treatment Studies (5 papers). L M Parker collaborates with scholars based in United States, Switzerland and Canada. L M Parker's co-authors include C. Thomas Griffiths, Ross S. Berkowitz, Robert C. Bast, R. C. Knapp, Jonathan M. Niloff, Thomas L. Klug, Thomas Leavitt, V R Zurawski, Hillard M. Lazarus and Eric L. Jenison and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

L M Parker

24 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer

1983 1.7k citations Robert C. Bast, Ross S. Berkowitz et al. profile →

Peers

L M Parker

ONCOL

SURGE

GENET

Klaske A. ten Hoor Netherlands

Gilad Ben‐Baruch Israel

Carolyn Y. Muller United States

Jean Hurteau United States

Ivo Meinhold‐Heerlein Germany

Kimio Ushijima Japan

Margaret M. Steinhoff United States

Andy Ryan United Kingdom

Karin Leunen Belgium

James V. Fiorica United States

Klaske A. ten Hoor Netherlands

L M Parker

757 ×0.6

1.1k ×1.4

ONCOL

734 ×1.2

309 ×0.7

SURGE

246 ×0.6

GENET

Citations per year, relative to L M Parker L M Parker (= 1×) peers Klaske A. ten Hoor

Countries citing papers authored by L M Parker

Since Specialization

Citations

This map shows the geographic impact of L M Parker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L M Parker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L M Parker more than expected).

Fields of papers citing papers by L M Parker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L M Parker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L M Parker. The network helps show where L M Parker may publish in the future.

Co-authorship network of co-authors of L M Parker

This figure shows the co-authorship network connecting the top 25 collaborators of L M Parker. A scholar is included among the top collaborators of L M Parker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L M Parker. L M Parker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schernhammer, Eva, Anita Giobbie‐Hurder, Jennifer Savoie, et al.. (2012). A randomized controlled trial of oral melatonin supplementation and breast cancer biomarkers. Cancer Causes & Control. 23(4). 609–616. 40 indexed citations

Berek, Jonathan S., L M Parker, Leslie R. DeMars, et al.. (2011). Catumaxomab treatment of malignant ascites in patients with chemotherapy-refractory ovarian cancer: A phase II study.. Journal of Clinical Oncology. 29(15_suppl). 5048–5048. 5 indexed citations

Piccart, Martine, L M Parker, & Kathleen I. Pritchard. (2003). Oestrogen receptor downregulation: an opportunity for extending the window of endocrine therapy in advanced breast cancer. Annals of Oncology. 14(7). 1017–1025. 18 indexed citations

Griffiths, C. Thomas, L M Parker, S Lee, & N. Finkler. (2002). The effect of residual mass size on response to chemotherapy after surgical cytoreduction for advanced ovarian cancer: Long-term results. International Journal of Gynecological Cancer. 12(4). 323–331. 25 indexed citations

Griffiths, C. Thomas, et al.. (2002). The effect of residual mass size on response to chemotherapy after surgical cytoreduction for advanced ovarian cancer: Long-term results. International Journal of Gynecological Cancer. 12(4). 323–331. 1 indexed citations

Osborne, C. Kent, John Pippen, Stephen E. Jones, et al.. (2002). Double-Blind, Randomized Trial Comparing the Efficacy and Tolerability of Fulvestrant Versus Anastrozole in Postmenopausal Women With Advanced Breast Cancer Progressing on Prior Endocrine Therapy: Results of a North American Trial. Journal of Clinical Oncology. 20(16). 3386–3395. 464 indexed citations

Burstein, HJ, Lyndsay N. Harris, Carolyn M. Kaelin, et al.. (2001). Preoperative trastuzumab (T) and paclitaxel (P) for HER2-overexpressing (HER2+) stage breast cancer. European Journal of Cancer. 37. S146–S146. 5 indexed citations

Nurnberg, H. George, et al.. (1999). Sildenafil for Women Patients With Antidepressant-Induced Sexual Dysfunction. Psychiatric Services. 50(8). 1076–1078. 64 indexed citations

Burstein, Harold J., William P. Petros, Kathryn Clarke, et al.. (1999). Phase I study of Doxil and vinorelbine in metastatic breast cancer. Annals of Oncology. 10(9). 1113–1116. 41 indexed citations

10.

Parker, L M, John Boyages, & T.J. Eberlein. (1992). Inflammatory carcinoma of the breast. 5 indexed citations

11.

Henderson, I. Craig, Daniel F. Hayes, L M Parker, et al.. (1990). Adjuvant systemic therapy for patients with node-negative tumors. Cancer. 65(S9). 2132–2147. 13 indexed citations

12.

Krag, Karen J., George P. Canellos, C. Thomas Griffiths, et al.. (1989). Predictive factors for long-term survival in patients with advanced ovarian cancer. Gynecologic Oncology. 34(1). 88–93. 32 indexed citations

13.

Bast, Robert C., Jonathan S. Berek, R. Obrist, et al.. (1983). Intraperitoneal immunotherapy of human ovarian carcinoma with Corynebacterium parvum.. PubMed. 43(3). 1395–401. 51 indexed citations

14.

Takvorian, Tak, L M Parker, Fred H. Hochberg, & George P. Canellos. (1983). Autologous bone-marrow transplantation: host effects of high-dose BCNU.. Journal of Clinical Oncology. 1(10). 610–620. 41 indexed citations

15.

Parker, L M, et al.. (1982). Effect of acyclovir and interferon on human hematopoietic progenitor cells. Antimicrobial Agents and Chemotherapy. 21(1). 146–150. 12 indexed citations

16.

Greenberg, Harvey, L M Parker, Peter E. Newburger, et al.. (1981). Corticosteroid Dependence of Continuous Hemopoiesis In Vitro with Murine or Human Bone Marrow. Hämatologie und Bluttransfusion. 26. 289–293. 7 indexed citations

17.

Kufe, DW, Patrick M. Beardsley, Daniel D. Karp, et al.. (1980). High-dose thymidine infusions in patients with leukemia and lymphoma.. Blood. 55(4). 580–9. 42 indexed citations

18.

Parker, L M, C. Thomas Griffiths, Ronald A. Yankee, R. C. Knapp, & George P. Canellos. (1979). High-dose methotrexate with leucovorin rescue in ovarian cancer: a phase II study.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 63(2). 275–9. 14 indexed citations

19.

Blum, Ronald H., G P Canellos, Robert J. Mayer, et al.. (1978). A therapeutic trial of maytansine.. PubMed. 1(2). 113–7. 25 indexed citations

20.

Tobias, Jeffrey, L M Parker, Martin H.N. Tattersall, & Emil Frei. (1975). Adriamycin/cyclophosphamide and adriamycin/melphalan in advanced L1210 leukaemia. British Journal of Cancer. 32(2). 199–207. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact